Abstract #0147

Impact of Single Fraction Stereotactic Radiosurgery vs. Hypofractionated Radiation Therapy on CEST and MT Parameters of Brain Metastases

Hatef Mehrabian¹, Wilfred W Lam¹, Hany Soliman^1,2,3, Sten Myrehaug^2,3, Arjun Sahgal^1,2,3, and Greg J Stanisz^1,4

¹Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada, ²Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ³Radiation Oncology, University of Toronto, Toronto, ON, Canada, ⁴Medical Biophysics, University of Toronto, Toronto, ON, Canada

Brain metastases are treated with single fraction stereotactic radiosurgery (sf-SRS) or hypofractionated radiation therapy (HFTR). CEST was previously shown to identify responders to sf-SRS within one-week post-treatment. This study investigated the differences in CEST and MT properties of brain metastases treated with sf-SRS and 5 fraction HFRT (5f-HFRT) one week after treatment. We observed statistically significantly larger reduction in CEST properties of tumours treated with sf-SRS compared to those treated with 5f-HFRT. However, changes in MT properties of the two cohort were similar. Such differences should be considered when evaluating response of brain metastases to radiotherapy using CEST and MT.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.